🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase🧪 Free 3mL BAC Water included in every purchase
CJC-1295 (No DAC) + Ipamorelin
Independently Verified
Growth HormoneIn Stock

GHRH/GHS-R Dual Secretagogue Blend

CJC-1295 (No DAC) + Ipamorelin

This research blend combines CJC-1295 without DAC (Modified GRF 1-29), a stabilized GHRH analog, with Ipamorelin, a selective GHS-R agonist. The two peptides act on distinct receptor pathways — GHRH receptors and ghrelin/GHS-R receptors respectively — producing synergistic, amplified pulsatile GH release in preclinical models. The combination is widely studied in GH axis research for its ability to maximize GH secretion while preserving physiological pulsatility and minimizing off-target effects on cortisol and prolactin.

3rd-Party Tested Intertek Pharmaceutical Services CoA Upon Request

Research Benefits

Key Research Applications

Documented areas of investigation based on peer-reviewed preclinical and clinical literature. For research reference only.

GH Axis Stimulation

Promotes natural, pulsatile growth hormone release from the anterior pituitary.

IGF-1 Elevation

Supports insulin-like growth factor-1 production for downstream anabolic signaling.

Body Composition

Studied for effects on lean mass, adipose tissue, and metabolic rate in research models.

Bone Density

Investigated for bone mineral density support in GH-deficient preclinical models.

Literature

Research Highlights

Synergistic GH release via simultaneous GHRH receptor and GHS-R activation in rodent models

Ipamorelin selectivity preserves cortisol and prolactin baseline in combination studies

Amplified IGF-1 elevation compared to either peptide administered alone in preclinical models

Physiological pulsatile GH secretion pattern maintained with dual-pathway stimulation

Specifications

Technical Data

Molecular Weight

Variable (dual-peptide blend)

Sequence / Structure

CJC-1295 (No DAC): Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH₂ | Ipamorelin: Aib-His-D-2-Nal-D-Phe-Lys-NH₂

Storage Conditions

Lyophilized: −20°C, stable 24 months. Reconstituted: 4°C, use within 28 days.

Solubility

Soluble in bacteriostatic water at ≥1 mg/mL

HPLC Purity

Verified — Batch VRC-CJI-2407

Testing Lab

Intertek Pharmaceutical Services · Jul 2026

Research Areas

GHRH AnalogGHS-RGH ReleaseSynergistic Blend

Ready to Order CJC-1295 (No DAC) + Ipamorelin?

CJC-1295 (No DAC) + Ipamorelin is currently in stock. View pricing, sizes, and the full Certificate of Analysis on the product page.

For Research Purposes Only. CJC-1295 (No DAC) + Ipamorelin is sold exclusively for in vitro laboratory research. Not for human consumption, diagnostic, therapeutic, or veterinary use. Research highlights are summaries of published preclinical and clinical studies and do not constitute medical advice or claims of efficacy. See our Research Use Disclaimer.